Mucosal immune responses

被引:77
|
作者
Acheson, DWK [1 ]
Luccioli, S [1 ]
机构
[1] US FDA, CFSAN, DHSS, College Pk, MD 20740 USA
关键词
mucosal immunity; intestinal epithelial cells; food-borne pathogens; gut-associated lymphoid tissue; follicle associated epithelia;
D O I
10.1016/j.bpg.2003.11.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The host gastrointestinal tract is exposed to countless numbers of foreign antigens and has embedded a unique and complex network of immunological and non-immunological mechanisms, often termed the gastrointestinal 'mucosal barrier', to protect the host from potentially harmful pathogens while at the same time 'tolerating' other resident microbes to allow absorption and utilization of nutrients. Of the many important roles of this barrier, it is the distinct responsibility of the mucosal immune system to sample and discriminate between harmful and beneficial antigens and to prevent entry of food-borne pathogens through the gastrointestinal (GI) tract. This system comprises an immunological network termed the gut-associated lymphoid tissue (GALT) that consists of unique arrangements of B cells, T cells and phagocytes which sample luminal antigens through specialized epithelia termed the follicle associated epithelia (FAE) and orchestrate co-ordinated molecular responses between immune cells and other components of the mucosal barrier. Certain pathogens have developed ways to bypass and/or withstand defence by the mucosal immune system to establish disease in the host. Some 'opportunistic' pathogens (such as Clostridium difficile) take advantage of host or other factors (diet, stress, antibiotic use) which may alter or weaken the response of the immune system. Other pathogens have developed mechanisms for invading gastrointestinal epithelium and evading phagocytosis/destruction by immune system defences. Once cellular invasion occurs, host responses are activated to limit local mucosal damage and repel the foreign influence. Some pathogens (Shigella spp, parasites and viruses) primarily establish localized disease while others (Salmonella, Yersinia, Listeria) use the lymphatic system to enter organs or the bloodstream and cause more systemic illness. In some cases, pathogens (Helicobacter pylori and Salmonella typhi) colonize the GI tract or associated lymphoid structures for extended periods of time and these persistent pathogens may also be potential triggers for other chronic or inflammatory diseases, including inflammatory bowel disease and malignancies. The ability of certain pathogens to avoid or withstand the host's immune assault and/or utilize these host responses to their own advantage (i.e. enhance further colonization) will dictate the pathogen's success in promoting illness and furthering its own survival.
引用
收藏
页码:387 / 404
页数:18
相关论文
共 50 条
  • [31] SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
    Puhach, Olha
    Bellon, Mathilde
    Adea, Kenneth
    Bekliz, Meriem
    Hosszu-Fellous, Krisztina
    Sattonnet, Pascale
    Hulo, Nicolas
    Kaiser, Laurent
    Eckerle, Isabella
    Meyer, Benjamin
    EBIOMEDICINE, 2023, 98
  • [32] Swine infection with Trichinella spiralis:: Comparative analysis of the mucosal intestinal and systemic immune responses
    Picherot, Melanie
    Oswald, Isabelle P.
    Cote, Martine
    Noeckler, Karsten
    Le Guerhier, Franck
    Boireau, Pascal
    Vallee, Isabelle
    VETERINARY PARASITOLOGY, 2007, 143 (02) : 122 - 130
  • [33] Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants
    Gherardi, MM
    Esteban, M
    VACCINE, 1999, 17 (9-10) : 1074 - 1083
  • [34] Participation of the intestinal epithelium and mast cells in local mucosal immune responses in commercial poultry
    Caldwell, DJ
    Danforth, HD
    Morris, BC
    Ameiss, KA
    McElroy, AP
    POULTRY SCIENCE, 2004, 83 (04) : 591 - 599
  • [35] The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
    Chan, Renee W. Y.
    Liu, Shaojun
    Cheung, Jonathan Y.
    Tsun, Joseph G. S.
    Chan, Kate C.
    Chan, Kathy Y. Y.
    Fung, Genevieve P. G.
    Li, Albert M.
    Lam, Hugh Simon
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] Associations between Mucosal Innate and Adaptive Immune Responses and Resolution of Diarrheal Pathogen Infections
    Long, Kurt Z.
    Rosado, Jorge L.
    Ignacio Santos, Jose
    Haas, Meredith
    Al Mamun, Abdullah
    DuPont, Herbert L.
    Nanthakumar, Nanda N.
    Estrada-Garcia, Teresa
    INFECTION AND IMMUNITY, 2010, 78 (03) : 1221 - 1228
  • [37] Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
    Kraynyak, K. A.
    Kutzler, M. A.
    Pahar, B.
    Sylvester, A.
    Yan, J.
    Carnathan, D.
    Khan, A. S.
    Sardesai, N.
    Moldoveanu, Z.
    Mestecky, J.
    Betts, M. R.
    Marx, P.
    Weiner, D. B.
    RETROVIROLOGY, 2009, 6
  • [38] Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
    Wang, Jialu
    Wang, Yongheng
    Zhang, En
    Zhou, Mengyun
    Lin, Jian
    Yang, Qian
    MICROBIAL CELL FACTORIES, 2019, 18 (1)
  • [39] The effect of Pediococcus acidilactici on mucosal immune responses, growth, and reproductive performance in zebrafish (Danio rerio)
    Arani, Mojtaba Mohammadi
    Salati, Amir Parviz
    Keyvanshokooh, Saeed
    Safari, Omid
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 2021, 47 (01) : 153 - 162
  • [40] Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
    Jialu Wang
    Yongheng Wang
    En Zhang
    Mengyun Zhou
    Jian Lin
    Qian Yang
    Microbial Cell Factories, 18